Ketorolac Tromethamine Injection, Solution
Product Images NDC 0409-3795

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 0409-3795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Ketorolac Tromethamine 01)

FDA Label Image

Structural Formula Of Ketorolac (Ketorolac Tromethamine 02)

Structural Formula Of Ketorolac (Ketorolac Tromethamine 02)
The text appears to be a chemical formula written as a combination of symbols and alphanumeric codes, followed by a figure label. Without additional context, it is difficult to provide a more specific description or interpretation of the text.*
FDA Label Image

Hospira Logo (Ketorolac Tromethamine 03)

FDA Label Image

Hospira Logo (Ketorolac Tromethamine 04)

FDA Label Image

Principal Display Panel (15 mg/mL Vial Label)

Principal Display Panel (15 mg/mL Vial Label)
1 mL Fill Single-dose NDC 0409-3793-19 is a solution of Ketorolac LR Tromethamine Inj, usp, for intravenous or intramuscular use, distributed by Hospira, Inc, located in Lake Forest, IL 60045 USA. The other characters are not available for interpretation.*
FDA Label Image

Principal Display Panel (15 mg/mL Vial Tray)

Principal Display Panel (15 mg/mL Vial Tray)
This is a description of a Ketorolac Tromethamine Injection, USP medicine which comes in a single-dose Flip-Top vial. The NDC of the product is 0409-3793-01 and each vial contains 15mg/mL of the medicine. It is used for Intravenous/Intramascular infusion and is distributed by Hospira Inc. based in Lake Forest, USA. The rest of the text is not readable.*
FDA Label Image

Principal Display Panel (30 mg/mL Vial Label)

Principal Display Panel (30 mg/mL Vial Label)
This is a single-dose injection of Ketorolac Tromethamine, intended for intravenous or intramuscular use. It comes in a 1mL fill size and is distributed by Hospira, Inc. based in Lake Forest, IL. The NDC code for this medicine is 0409-3795-19. The rest of the text is not legible or unavailable.*
FDA Label Image

Principal Display Panel (30 mg/mL Vial Tray)

Principal Display Panel (30 mg/mL Vial Tray)
This is a prescription drug in a single-dose Flip-top vial containing 30mg/mL Ketorolac Tromethamine Injection, USP. It is for intravenous or intramuscular use only and manufactured by Hospira. The text seems to include some type of code or serial number, but it is not possible to read it correctly.*
FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
This is a description of a medication called Ketorolac Tromethamine Injection. It is in single-dose form and comes in a 2 mL bottle with a National Drug Code (NDC) of 0409-3796-19. The medication is only for medical use and is distributed by Hospira, located in Lake Forest, IL, USA. The dosage information is unreadable, as the text appears to have errors from the .*
FDA Label Image

Principal Display Panel (2 mL Vial Tray)

Principal Display Panel (2 mL Vial Tray)
This appears to be a description of a medication that comes in a single-dose vial. The medication is Ketorolac Tromethamine, an injection used for pain relief. The vial is made by Hospira and has an NDC code of 0409-3796-07. The vial contains 30mg/mL of the medication. There is some additional text that appears to be a code or identifier for the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.